(-)-epigallocatechin 3-gallate multiple interactions ISO MYBL1 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MYBL1 mRNA CTD PMID:22079256 (S)-amphetamine decreases expression ISO Mybl1 (Mus musculus) 6480464 Dextroamphetamine results in decreased expression of MYBL1 mRNA CTD PMID:12205029 (S)-amphetamine multiple interactions ISO Mybl1 (Mus musculus) 6480464 SOD1 inhibits the reaction [Dextroamphetamine results in decreased expression of MYBL1 mRNA] CTD PMID:12205029 1,1-dichloroethene increases expression ISO Mybl1 (Mus musculus) 6480464 vinylidene chloride results in increased expression of MYBL1 mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions EXP 6480464 [APC protein affects the susceptibility to 1 and 2-Dimethylhydrazine] which results in decreased expression of MYBL1 mRNA CTD PMID:27840820 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of MYBL1 mRNA CTD PMID:30723492 17beta-estradiol multiple interactions ISO MYBL1 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of MYBL1 mRNA more ... CTD PMID:19619570 more ... 17beta-estradiol increases expression ISO MYBL1 (Homo sapiens) 6480464 Estradiol results in increased expression of MYBL1 mRNA CTD PMID:15913882 more ... 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of MYBL1 mRNA CTD PMID:26496021 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO MYBL1 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of MYBL1 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MYBL1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Mybl1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of MYBL1 mRNA CTD PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Mybl1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of MYBL1 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MYBL1 mRNA CTD PMID:22298810 and PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO MYBL1 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of MYBL1 mRNA CTD PMID:17517823 more ... 2-acetamidofluorene increases expression ISO Mybl1 (Mus musculus) 6480464 2-Acetylaminofluorene results in increased expression of MYBL1 mRNA CTD PMID:21607683 2-palmitoylglycerol increases expression ISO MYBL1 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of MYBL1 mRNA CTD PMID:37199045 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO MYBL1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of MYBL1 mRNA CTD PMID:28628672 3-methylcholanthrene affects expression ISO Mybl1 (Mus musculus) 6480464 Methylcholanthrene affects the expression of MYBL1 mRNA CTD PMID:35487396 4,4'-sulfonyldiphenol multiple interactions ISO MYBL1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of MYBL1 mRNA CTD PMID:28628672 acetamide increases expression EXP 6480464 acetamide results in increased expression of MYBL1 mRNA CTD PMID:31881176 afimoxifene increases expression ISO MYBL1 (Homo sapiens) 6480464 afimoxifene results in increased expression of MYBL1 mRNA CTD PMID:19901195 aflatoxin B1 affects expression ISO MYBL1 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of MYBL1 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of MYBL1 mRNA CTD PMID:23630614 more ... aflatoxin B1 increases expression ISO MYBL1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of MYBL1 mRNA CTD PMID:22100608 Alisol A multiple interactions EXP 6480464 [alisol A co-treated with alisol A 24-acetate co-treated with alisol B co-treated with alisol B 23-acetate co-treated with alisol C 23-acetate co-treated with alisol F co-treated with alisol F 24-acetate] results in decreased expression of MYBL1 mRNA CTD PMID:33035272 Alisol B multiple interactions EXP 6480464 [alisol A co-treated with alisol A 24-acetate co-treated with alisol B co-treated with alisol B 23-acetate co-treated with alisol C 23-acetate co-treated with alisol F co-treated with alisol F 24-acetate] results in decreased expression of MYBL1 mRNA CTD PMID:33035272 Alisol C 23-acetate multiple interactions EXP 6480464 [alisol A co-treated with alisol A 24-acetate co-treated with alisol B co-treated with alisol B 23-acetate co-treated with alisol C 23-acetate co-treated with alisol F co-treated with alisol F 24-acetate] results in decreased expression of MYBL1 mRNA CTD PMID:33035272 all-trans-retinoic acid decreases expression ISO Mybl1 (Mus musculus) 6480464 Tretinoin results in decreased expression of MYBL1 mRNA CTD PMID:16604517 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of MYBL1 mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO MYBL1 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of MYBL1 mRNA CTD PMID:24449571 apigenin multiple interactions ISO MYBL1 (Homo sapiens) 6480464 Fulvestrant inhibits the reaction [Apigenin results in increased expression of MYBL1 mRNA] CTD PMID:33405908 apigenin increases expression ISO MYBL1 (Homo sapiens) 6480464 Apigenin results in increased expression of MYBL1 mRNA CTD PMID:33405908 aristolochic acid A multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of MYBL1 mRNA CTD PMID:23912714 arsenous acid decreases expression ISO MYBL1 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of MYBL1 mRNA CTD PMID:15725085 more ... azathioprine decreases expression ISO MYBL1 (Homo sapiens) 6480464 Azathioprine results in decreased expression of MYBL1 mRNA CTD PMID:22623647 azoxystrobin decreases expression ISO MYBL1 (Homo sapiens) 6480464 azoxystrobin results in decreased expression of MYBL1 mRNA CTD PMID:33512557 bazedoxifene decreases expression ISO MYBL1 (Homo sapiens) 6480464 bazedoxifene results in decreased expression of MYBL1 mRNA CTD PMID:19914376 benzo[a]pyrene increases expression ISO Mybl1 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of MYBL1 mRNA CTD PMID:21715664 benzo[a]pyrene increases expression ISO MYBL1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of MYBL1 mRNA CTD PMID:21632981 more ... benzo[a]pyrene diol epoxide I increases expression ISO MYBL1 (Homo sapiens) 6480464 7 more ... CTD PMID:26238291 bisphenol A increases expression ISO Mybl1 (Mus musculus) 6480464 bisphenol A results in increased expression of MYBL1 mRNA CTD PMID:20739668 bisphenol A decreases expression ISO MYBL1 (Homo sapiens) 6480464 bisphenol A results in decreased expression of MYBL1 mRNA CTD PMID:29275510 bisphenol A increases expression ISO MYBL1 (Homo sapiens) 6480464 bisphenol A results in increased expression of MYBL1 mRNA CTD PMID:28711546 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MYBL1 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of MYBL1 mRNA CTD PMID:26496021 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of MYBL1 mRNA CTD PMID:32479839 chloropicrin increases expression ISO MYBL1 (Homo sapiens) 6480464 chloropicrin results in increased expression of MYBL1 mRNA CTD PMID:28476498 chlorpyrifos decreases expression ISO Mybl1 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of MYBL1 mRNA CTD PMID:37019170 chrysin increases expression ISO MYBL1 (Homo sapiens) 6480464 chrysin results in increased expression of MYBL1 mRNA CTD PMID:33405908 chrysin multiple interactions ISO MYBL1 (Homo sapiens) 6480464 Fulvestrant inhibits the reaction [chrysin results in increased expression of MYBL1 mRNA] CTD PMID:33405908 cisplatin multiple interactions ISO MYBL1 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of MYBL1 mRNA CTD PMID:27392435 clofibrate multiple interactions ISO Mybl1 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of MYBL1 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MYBL1 mRNA] CTD PMID:17585979 clomiphene decreases expression ISO MYBL1 (Homo sapiens) 6480464 Clomiphene results in decreased expression of MYBL1 mRNA CTD PMID:26865669 copper(II) sulfate decreases expression ISO MYBL1 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of MYBL1 mRNA CTD PMID:19549813 coumarin decreases phosphorylation ISO MYBL1 (Homo sapiens) 6480464 coumarin results in decreased phosphorylation of MYBL1 protein CTD PMID:35688186 crocidolite asbestos decreases expression ISO MYBL1 (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased expression of MYBL1 mRNA CTD PMID:29523930 CU-O LINKAGE decreases expression ISO MYBL1 (Homo sapiens) 6480464 cupric oxide results in decreased expression of MYBL1 mRNA CTD PMID:22077320 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of MYBL1 mRNA CTD PMID:27523638 cyclosporin A decreases expression ISO MYBL1 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of MYBL1 mRNA CTD PMID:20106945 more ... cyclosporin A increases expression ISO MYBL1 (Homo sapiens) 6480464 Cyclosporine results in increased expression of MYBL1 mRNA CTD PMID:33631201 cyproterone multiple interactions ISO MYBL1 (Homo sapiens) 6480464 Fulvestrant inhibits the reaction [Cyproterone results in increased expression of MYBL1 mRNA] CTD PMID:33405908 cyproterone increases expression ISO MYBL1 (Homo sapiens) 6480464 Cyproterone results in increased expression of MYBL1 mRNA CTD PMID:33405908 daidzein increases expression ISO MYBL1 (Homo sapiens) 6480464 daidzein results in increased expression of MYBL1 mRNA CTD PMID:33405908 daidzein multiple interactions ISO MYBL1 (Homo sapiens) 6480464 Fulvestrant inhibits the reaction [daidzein results in increased expression of MYBL1 mRNA] CTD PMID:33405908 deguelin decreases expression ISO MYBL1 (Homo sapiens) 6480464 deguelin results in decreased expression of MYBL1 mRNA CTD PMID:33512557 dexamethasone multiple interactions ISO MYBL1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of MYBL1 mRNA CTD PMID:28628672 diarsenic trioxide decreases expression ISO MYBL1 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of MYBL1 mRNA CTD PMID:15725085 more ... dichloroacetic acid increases expression ISO Mybl1 (Mus musculus) 6480464 Dichloroacetic Acid results in increased expression of MYBL1 mRNA CTD PMID:28962523 diethylstilbestrol increases expression ISO MYBL1 (Homo sapiens) 6480464 Diethylstilbestrol results in increased expression of MYBL1 mRNA CTD PMID:26865669 dimethylarsinic acid multiple interactions ISO Mybl1 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MYBL1 mRNA CTD PMID:34876320 dioxygen decreases expression ISO MYBL1 (Homo sapiens) 6480464 Oxygen deficiency results in decreased expression of MYBL1 mRNA CTD PMID:26516004 dioxygen multiple interactions ISO Mybl1 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYBL1 mRNA CTD PMID:30529165 disodium selenite decreases expression ISO MYBL1 (Homo sapiens) 6480464 Sodium Selenite results in decreased expression of MYBL1 mRNA CTD PMID:18175754 dorsomorphin multiple interactions ISO MYBL1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO MYBL1 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of MYBL1 mRNA CTD PMID:29803840 doxorubicin increases expression ISO Mybl1 (Mus musculus) 6480464 Doxorubicin results in increased expression of MYBL1 mRNA CTD PMID:36227756 Echimidine increases expression EXP 6480464 echimidine results in increased expression of MYBL1 mRNA CTD PMID:32419051 estrone increases expression ISO MYBL1 (Homo sapiens) 6480464 Estrone results in increased expression of MYBL1 mRNA CTD PMID:26865669 ethisterone multiple interactions ISO MYBL1 (Homo sapiens) 6480464 Fulvestrant inhibits the reaction [Ethisterone results in increased expression of MYBL1 mRNA] CTD PMID:33405908 ethisterone increases expression ISO MYBL1 (Homo sapiens) 6480464 Ethisterone results in increased expression of MYBL1 mRNA CTD PMID:33405908 ethyl methanesulfonate increases expression ISO MYBL1 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of MYBL1 mRNA CTD PMID:23649840 fenamidone increases expression ISO Mybl1 (Mus musculus) 6480464 fenamidone results in increased expression of MYBL1 mRNA CTD PMID:27029645 fentin chloride decreases expression EXP 6480464 triphenyltin chloride results in decreased expression of MYBL1 mRNA CTD PMID:37156404 folic acid decreases expression ISO MYBL1 (Homo sapiens) 6480464 Folic Acid results in decreased expression of MYBL1 mRNA CTD PMID:21867686 formaldehyde increases expression ISO MYBL1 (Homo sapiens) 6480464 Formaldehyde results in increased expression of MYBL1 mRNA CTD PMID:23649840 FR900359 decreases phosphorylation ISO MYBL1 (Homo sapiens) 6480464 FR900359 results in decreased phosphorylation of MYBL1 protein CTD PMID:37730182 fulvestrant multiple interactions ISO MYBL1 (Homo sapiens) 6480464 Fulvestrant inhibits the reaction [Apigenin results in increased expression of MYBL1 mRNA] more ... CTD PMID:33405908 fulvestrant decreases expression ISO MYBL1 (Homo sapiens) 6480464 Fulvestrant results in decreased expression of MYBL1 mRNA CTD PMID:26865669 and PMID:33405908 furan increases expression EXP 6480464 furan results in increased expression of MYBL1 mRNA CTD PMID:25539665 furan decreases expression EXP 6480464 furan results in decreased expression of MYBL1 mRNA CTD PMID:27387713 furan increases methylation EXP 6480464 furan results in increased methylation of MYBL1 gene CTD PMID:27387713 genistein decreases expression ISO MYBL1 (Homo sapiens) 6480464 Genistein results in decreased expression of MYBL1 mRNA CTD PMID:22228119 genistein increases expression ISO MYBL1 (Homo sapiens) 6480464 Genistein results in increased expression of MYBL1 mRNA CTD PMID:26865669 geraniol decreases expression ISO MYBL1 (Homo sapiens) 6480464 geraniol results in decreased expression of MYBL1 mRNA CTD PMID:27683099 GW 4064 increases expression ISO Mybl1 (Mus musculus) 6480464 GW 4064 results in increased expression of MYBL1 mRNA CTD PMID:26655953 Heliotrine increases expression EXP 6480464 heliotrine results in increased expression of MYBL1 mRNA CTD PMID:32419051 hexestrol increases expression ISO MYBL1 (Homo sapiens) 6480464 Hexestrol results in increased expression of MYBL1 mRNA CTD PMID:26865669 indometacin multiple interactions ISO MYBL1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of MYBL1 mRNA CTD PMID:28628672 ivermectin multiple interactions ISO MYBL1 (Homo sapiens) 6480464 ESR1 protein affects the reaction [Ivermectin results in increased expression of MYBL1 mRNA] CTD PMID:33405908 ivermectin increases expression ISO MYBL1 (Homo sapiens) 6480464 Ivermectin results in increased expression of MYBL1 mRNA CTD PMID:33405908 kaempferol multiple interactions ISO MYBL1 (Homo sapiens) 6480464 Fulvestrant inhibits the reaction [kaempferol results in increased expression of MYBL1 mRNA] CTD PMID:33405908 kaempferol increases expression ISO MYBL1 (Homo sapiens) 6480464 kaempferol results in increased expression of MYBL1 mRNA CTD PMID:33405908 Lasiocarpine increases expression EXP 6480464 lasiocarpine results in increased expression of MYBL1 mRNA CTD PMID:32419051 lead diacetate decreases expression ISO Mybl1 (Mus musculus) 6480464 lead acetate results in decreased expression of MYBL1 mRNA CTD PMID:22609695 lipopolysaccharide decreases expression ISO MYBL1 (Homo sapiens) 6480464 Lipopolysaccharides results in decreased expression of MYBL1 mRNA CTD PMID:18192897 Lynestrenol increases expression ISO MYBL1 (Homo sapiens) 6480464 Lynestrenol results in increased expression of MYBL1 mRNA CTD PMID:33405908 Lynestrenol multiple interactions ISO MYBL1 (Homo sapiens) 6480464 Fulvestrant inhibits the reaction [Lynestrenol results in increased expression of MYBL1 mRNA] CTD PMID:33405908 mestranol increases expression ISO MYBL1 (Homo sapiens) 6480464 Mestranol results in increased expression of MYBL1 mRNA CTD PMID:26865669 methyl methanesulfonate increases expression ISO MYBL1 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of MYBL1 mRNA CTD PMID:23649840 methylarsonic acid multiple interactions ISO Mybl1 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MYBL1 mRNA CTD PMID:34876320 methylparaben decreases expression ISO MYBL1 (Homo sapiens) 6480464 methylparaben results in decreased expression of MYBL1 mRNA CTD PMID:31745603 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO MYBL1 (Homo sapiens) 6480464 Methylnitronitrosoguanidine results in increased expression of MYBL1 mRNA CTD PMID:12634122 N-nitrosodiethylamine increases expression ISO Mybl1 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of MYBL1 mRNA CTD PMID:21607683 nickel atom increases expression ISO MYBL1 (Homo sapiens) 6480464 Nickel results in increased expression of MYBL1 mRNA CTD PMID:25583101 norethisterone multiple interactions ISO MYBL1 (Homo sapiens) 6480464 Fulvestrant inhibits the reaction [Norethindrone results in increased expression of MYBL1 mRNA] CTD PMID:33405908 norethisterone increases expression ISO MYBL1 (Homo sapiens) 6480464 Norethindrone results in increased expression of MYBL1 mRNA CTD PMID:33405908 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of MYBL1 mRNA CTD PMID:30449730 oxybenzone increases expression ISO MYBL1 (Homo sapiens) 6480464 oxybenzone results in increased expression of MYBL1 mRNA CTD PMID:33405908 oxybenzone multiple interactions ISO MYBL1 (Homo sapiens) 6480464 Fulvestrant inhibits the reaction [oxybenzone results in increased expression of MYBL1 mRNA] CTD PMID:33405908 ozone multiple interactions ISO Mybl1 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MYBL1 mRNA CTD PMID:34911549 panobinostat increases expression ISO MYBL1 (Homo sapiens) 6480464 Panobinostat results in increased expression of MYBL1 mRNA CTD PMID:33770205 paracetamol multiple interactions ISO Mybl1 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of MYBL1 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MYBL1 mRNA] CTD PMID:17585979 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MYBL1 mRNA CTD PMID:33387578 paracetamol increases expression ISO MYBL1 (Homo sapiens) 6480464 Acetaminophen results in increased expression of MYBL1 mRNA CTD PMID:22230336 paraquat increases expression EXP 6480464 Paraquat results in increased expression of MYBL1 mRNA CTD PMID:32680482 paraquat decreases expression ISO MYBL1 (Homo sapiens) 6480464 Paraquat results in decreased expression of MYBL1 mRNA CTD PMID:35182771 perfluorooctanoic acid decreases expression ISO MYBL1 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of MYBL1 mRNA CTD PMID:36326898 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of MYBL1 mRNA CTD PMID:18158353 phenylmercury acetate decreases expression ISO MYBL1 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of MYBL1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO MYBL1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYBL1 mRNA CTD PMID:27188386 phytoestrogen increases expression ISO MYBL1 (Homo sapiens) 6480464 Phytoestrogens results in increased expression of MYBL1 mRNA CTD PMID:18310284 pirinixic acid increases expression ISO Mybl1 (Mus musculus) 6480464 pirinixic acid results in increased expression of MYBL1 mRNA CTD PMID:20813756 pirinixic acid multiple interactions ISO Mybl1 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MYBL1 mRNA CTD PMID:19710929 potassium chromate decreases expression ISO MYBL1 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of MYBL1 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO MYBL1 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MYBL1 mRNA CTD PMID:22079256 potassium dichromate decreases expression ISO Mybl1 (Mus musculus) 6480464 Potassium Dichromate results in decreased expression of MYBL1 mRNA CTD PMID:23608068 pregnenolone increases expression ISO MYBL1 (Homo sapiens) 6480464 Pregnenolone results in increased expression of MYBL1 mRNA CTD PMID:33405908 pregnenolone multiple interactions ISO MYBL1 (Homo sapiens) 6480464 Fulvestrant inhibits the reaction [Pregnenolone results in increased expression of MYBL1 mRNA] CTD PMID:33405908 progesterone multiple interactions ISO MYBL1 (Homo sapiens) 6480464 Fulvestrant inhibits the reaction [Progesterone results in increased expression of MYBL1 mRNA] CTD PMID:33405908 progesterone increases expression ISO MYBL1 (Homo sapiens) 6480464 Progesterone results in increased expression of MYBL1 mRNA CTD PMID:33405908 quercetin increases expression ISO MYBL1 (Homo sapiens) 6480464 Quercetin results in increased expression of MYBL1 mRNA CTD PMID:21632981 raloxifene decreases expression ISO MYBL1 (Homo sapiens) 6480464 Raloxifene Hydrochloride results in decreased expression of MYBL1 mRNA CTD PMID:26865669 raloxifene multiple interactions ISO MYBL1 (Homo sapiens) 6480464 [Raloxifene Hydrochloride co-treated with Estradiol] results in decreased expression of MYBL1 mRNA CTD PMID:21185374 rotenone decreases expression ISO MYBL1 (Homo sapiens) 6480464 Rotenone results in decreased expression of MYBL1 mRNA CTD PMID:33512557 SB 431542 multiple interactions ISO MYBL1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 senecionine increases expression EXP 6480464 senecionine results in increased expression of MYBL1 mRNA CTD PMID:32419051 Senkirkine increases expression EXP 6480464 senkirkine results in increased expression of MYBL1 mRNA CTD PMID:32419051 silicon dioxide increases expression ISO MYBL1 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of MYBL1 mRNA CTD PMID:25895662 silicon dioxide decreases expression ISO MYBL1 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of MYBL1 mRNA CTD PMID:23806026 silver atom decreases expression ISO Mybl1 (Mus musculus) 6480464 Silver results in decreased expression of MYBL1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO Mybl1 (Mus musculus) 6480464 Silver results in decreased expression of MYBL1 mRNA CTD PMID:27131904 sodium arsenate multiple interactions ISO Mybl1 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MYBL1 mRNA CTD PMID:34876320 sodium arsenite decreases expression ISO Mybl1 (Mus musculus) 6480464 sodium arsenite results in decreased expression of MYBL1 mRNA CTD PMID:16014739 sodium arsenite multiple interactions ISO Mybl1 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MYBL1 mRNA CTD PMID:34876320 sodium arsenite increases expression ISO MYBL1 (Homo sapiens) 6480464 sodium arsenite results in increased expression of MYBL1 mRNA CTD PMID:17879257 and PMID:29301061 spironolactone multiple interactions ISO MYBL1 (Homo sapiens) 6480464 Fulvestrant inhibits the reaction [Spironolactone results in increased expression of MYBL1 mRNA] CTD PMID:33405908 spironolactone increases expression ISO MYBL1 (Homo sapiens) 6480464 Spironolactone results in increased expression of MYBL1 mRNA CTD PMID:33405908 sunitinib decreases expression ISO MYBL1 (Homo sapiens) 6480464 Sunitinib results in decreased expression of MYBL1 mRNA CTD PMID:31533062 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of MYBL1 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO Mybl1 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of MYBL1 mRNA CTD PMID:29987408 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MYBL1 mRNA CTD PMID:23411599 and PMID:34492290 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of MYBL1 mRNA CTD PMID:33387578 trichostatin A increases expression ISO MYBL1 (Homo sapiens) 6480464 trichostatin A results in increased expression of MYBL1 mRNA CTD PMID:24935251 trichostatin A affects expression ISO MYBL1 (Homo sapiens) 6480464 trichostatin A affects the expression of MYBL1 mRNA CTD PMID:28542535 Triptolide increases expression ISO Mybl1 (Mus musculus) 6480464 triptolide results in increased expression of MYBL1 mRNA CTD PMID:32835833 triptonide increases expression ISO Mybl1 (Mus musculus) 6480464 triptonide results in increased expression of MYBL1 mRNA CTD PMID:33045310 urethane increases expression ISO MYBL1 (Homo sapiens) 6480464 Urethane results in increased expression of MYBL1 mRNA CTD PMID:28818685 valproic acid affects expression ISO MYBL1 (Homo sapiens) 6480464 Valproic Acid affects the expression of MYBL1 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO MYBL1 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYBL1 mRNA CTD PMID:27188386 valproic acid increases expression ISO MYBL1 (Homo sapiens) 6480464 Valproic Acid results in increased expression of MYBL1 mRNA CTD PMID:19101580 more ... vorinostat increases expression ISO MYBL1 (Homo sapiens) 6480464 vorinostat results in increased expression of MYBL1 mRNA CTD PMID:27188386